Compare Revolution Medicines Inc. Common Stock (RVMD) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revolution Medicines Inc. Common Stock vs AT&T Inc. — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while AT&T Inc. trades at $22.18 (market cap $170.42B). The key difference: AT&T Inc. is far larger — about 4.2× Revolution Medicines Inc. Common Stock's market cap, and AT&T Inc. pays a 4.46% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and AT&T Inc. for 118 Days on average.
| RVMD | T | |
|---|---|---|
Market Cap | $40.32B | $170.42B |
Volume | 4,855,734 | 50,780,036 |
Sector | Health | Media |
52-Week High | $221.15 | $29.10 |
52-Week Low | $47.50 | $20.49 |
Typical Hold Time | 0 Days | 118 Days |
Enterprise Value | $37.02B | $315.74B |
Dividend Yield | — | 4.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AT&T (T) trades at $24.885, up 1.68% over 24 hours, with a bullish technical signal despite mixed moving averages and oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Fundamentals show solid profitability with a 16.94% net margin and attractive valuation metrics, including a P/E of 8.21. Recent news highlights a $3 billion fiber deal with Corning and joint venture developments with telecom peers to expand coverage.
The outlook for AT&T is cautiously optimistic, supported by earnings momentum and strategic investments in fiber and AI infrastructure. Key risks include high debt levels, competitive pressures, and potential dividend sustainability concerns. Analyst consensus leans neutral with a $27.50 price target, suggesting moderate upside from current levels amid balanced sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
